Evidence-based treatment of urticaria;Evidenzbasierte therapie bei urtikaria

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 28-29, 2006, Pages 1601-1604

  Wedi, Bettina ^a   Kapp, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

H 1 receptor antagonists; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; ANTIRHEUMATIC AGENT; BETAMETHASONE; CETIRIZINE; CYCLOSPORIN A; DAPSONE; DESLORATADINE; DEXCHLORPHENIRAMINE; DIMETINDENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EBASTINE; FEXOFENADINE; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYCHLOROQUINE; HYDROXYZINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LORATADINE; METHYLPREDNISOLONE; MIZOLASTINE; MONTELUKAST; PREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; TRIAMCINOLONE; UNINDEXED DRUG;

ANAPHYLAXIS; CHRONIC URTICARIA; DISEASE CLASSIFICATION; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; HUMAN; PERSISTENT INFECTION; REMISSION; REVIEW; URTICARIA;

ACUTE DISEASE; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; URTICARIA;

EID: 33746808549     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947804     Document Type: Review

References (16)

1. Dreskin SC, Andrews KY. The thyroid and urticaria. Curr Opin Allergy Clin Immunol 2005; 5: 408-412
2. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003; 49: 861-864
3. Raap U, Liekenbrocker T, Wieczorek D, Kapp A, Wedi B. Neue Therapieoptionen der Urtikaria und ihrer Subtypen. Hautarzt 2004; 55: 361-366
4. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol 1995; 95: 685-693
5. Wedi B, Kapp A. Chronic urticaria. G Ital Dermatol Venereol 2005; 140: 435-443
6. Wedi B, Kapp A. Chronic urticaria: assessment of current treatment. Exp Rev Clin Immunol 2005; 1: 459-473
7. Wedi B, Kapp A. Aktuelle Positionsbestimmung zur Bedeutung von Nahrungsmittelallergien und -Unverträglichkeiten bei der Urtikaria. Hautarzt 2006; 57: 101-107
8. Wedi B. Novacovic V, Koemer M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression - inhibitory effects of anti-inflammatory drugs. Journal of Allergy and Clinical Immunology 2000; 105: 552-560
9. Wedi B, Raap U, Kapp A. Chronic urticaria and infections. Curr Opin Allergy Clin Immunol 2004; 4: 387-396
10. Wedi B, Raap U, Wieczorek D, Kapp A. Neues zur Urtikaria. Allergologie 2004; 27: 435-443
11. Werfel T, Wedi B, Kleine-Tebbe J, Niggemann B, Saloga J, Sennekamp J, Vieluf I, Vieths S, Zuberbier T, Jäger L. Vorgehen bei Verdacht auf eine pseudo-allergische Reaktion durch Nahrungsmittelinhaltsstoffe. Allergo J 1999; 8: 135-141
12. Wieczorek D, Raap U, Liekenbrocker T, Kapp A, Wedi B. Chronische Urtikaria im Kindesalter. Hautarzt 2004; 55: 357-360
13. Zuberbier T, Aberer W, Grabbe J, Hartmann K, Merk H, Ollert M. Rueff F. Wedi B, Wenning J. In Process Citation. J Dtsch Dermatol Ges 2003; 1: 655-664
14. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schafer T, Simon D, Vena GA, Wedi B. EAACI/GALEN/EDF guideline: definition, classification and diagnosis of urticaria. Allergy 2006; 61: 316-320
15. Zuberbier T, Bindslev-Jensen C, Canonica W, Grattan CE, Greaves MW, Henz BM, Kapp A, Kozel MM, Maurer M, Merk HF, Schafer T, Simon D, Vena GA, Wedi B. EAACI/GALEN/EDF guideline: management of urticaria. Allergy 2006; 61: 321-331
16. Zuberbier T, Chantraine-Hess S, Hartmann K, Czarnetzki BM. Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995; 75: 484-487